nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—NOS2—Doxorubicin—testicular cancer	0.0791	0.109	CbGbCtD
Dexamethasone—CYP4A11—Cisplatin—testicular cancer	0.0678	0.0936	CbGbCtD
Dexamethasone—SLCO1A2—Chlorambucil—testicular cancer	0.0647	0.0894	CbGbCtD
Dexamethasone—ABCB11—Vinblastine—testicular cancer	0.0307	0.0424	CbGbCtD
Dexamethasone—CYP2A6—Ifosfamide—testicular cancer	0.0297	0.041	CbGbCtD
Dexamethasone—ABCG2—Dactinomycin—testicular cancer	0.0233	0.0322	CbGbCtD
Dexamethasone—NR0B1—seminiferous tubule of testis—testicular cancer	0.0214	0.185	CbGeAlD
Dexamethasone—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0203	0.0281	CbGbCtD
Dexamethasone—CYP3A7—Ifosfamide—testicular cancer	0.0203	0.0281	CbGbCtD
Dexamethasone—CYP2B6—Ifosfamide—testicular cancer	0.0194	0.0267	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—testicular cancer	0.0189	0.0261	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—testicular cancer	0.0189	0.0261	CbGbCtD
Dexamethasone—ABCC2—Carboplatin—testicular cancer	0.0173	0.0239	CbGbCtD
Dexamethasone—ABCC2—Vinblastine—testicular cancer	0.0162	0.0223	CbGbCtD
Dexamethasone—ABCG2—Carboplatin—testicular cancer	0.0157	0.0216	CbGbCtD
Dexamethasone—CYP3A5—Ifosfamide—testicular cancer	0.0153	0.021	CbGbCtD
Dexamethasone—ABCC2—Cisplatin—testicular cancer	0.0148	0.0204	CbGbCtD
Dexamethasone—CYP2C8—Ifosfamide—testicular cancer	0.0147	0.0202	CbGbCtD
Dexamethasone—PTGS2—Cisplatin—testicular cancer	0.0146	0.0202	CbGbCtD
Dexamethasone—ABCC2—Etoposide—testicular cancer	0.0146	0.0201	CbGbCtD
Dexamethasone—PTGS2—Etoposide—testicular cancer	0.0144	0.0198	CbGbCtD
Dexamethasone—ABCG2—Cisplatin—testicular cancer	0.0134	0.0185	CbGbCtD
Dexamethasone—ABCG2—Etoposide—testicular cancer	0.0132	0.0182	CbGbCtD
Dexamethasone—CYP2C19—Ifosfamide—testicular cancer	0.0123	0.017	CbGbCtD
Dexamethasone—SLCO1A2—Methotrexate—testicular cancer	0.0116	0.016	CbGbCtD
Dexamethasone—CYP11A1—corpus luteum—testicular cancer	0.0115	0.0994	CbGeAlD
Dexamethasone—CYP17A1—seminiferous tubule of testis—testicular cancer	0.0104	0.0905	CbGeAlD
Dexamethasone—CYP2C9—Ifosfamide—testicular cancer	0.0102	0.0141	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—testicular cancer	0.00992	0.0137	CbGbCtD
Dexamethasone—CYP11A1—seminiferous tubule of testis—testicular cancer	0.00971	0.0842	CbGeAlD
Dexamethasone—ABCC2—Methotrexate—testicular cancer	0.00961	0.0133	CbGbCtD
Dexamethasone—CYP2B6—Cisplatin—testicular cancer	0.00942	0.013	CbGbCtD
Dexamethasone—CYP2E1—Etoposide—testicular cancer	0.00938	0.0129	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—testicular cancer	0.00897	0.0124	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—testicular cancer	0.00869	0.012	CbGbCtD
Dexamethasone—ABCB1—Dactinomycin—testicular cancer	0.00841	0.0116	CbGbCtD
Dexamethasone—PGR—corpus luteum—testicular cancer	0.00827	0.0717	CbGeAlD
Dexamethasone—CYP19A1—corpus luteum—testicular cancer	0.00744	0.0646	CbGeAlD
Dexamethasone—CYP3A5—Etoposide—testicular cancer	0.00729	0.0101	CbGbCtD
Dexamethasone—CYP2C8—Etoposide—testicular cancer	0.00701	0.00967	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—testicular cancer	0.00631	0.00871	CbGbCtD
Dexamethasone—CYP19A1—seminiferous tubule of testis—testicular cancer	0.00631	0.0547	CbGeAlD
Dexamethasone—CYP3A4—Ifosfamide—testicular cancer	0.00595	0.00821	CbGbCtD
Dexamethasone—ABCB1—Vinblastine—testicular cancer	0.00527	0.00727	CbGbCtD
Dexamethasone—CYP2C9—Cisplatin—testicular cancer	0.00497	0.00687	CbGbCtD
Dexamethasone—CYP2D6—Vinblastine—testicular cancer	0.00496	0.00685	CbGbCtD
Dexamethasone—ABCB1—Cisplatin—testicular cancer	0.00483	0.00666	CbGbCtD
Dexamethasone—ABCB1—Etoposide—testicular cancer	0.00474	0.00655	CbGbCtD
Dexamethasone—CYP19A1—semen—testicular cancer	0.00349	0.0302	CbGeAlD
Dexamethasone—PGR—Ovarian Infertility Genes—DAZL—testicular cancer	0.00341	0.166	CbGpPWpGaD
Dexamethasone—ABCB1—Doxorubicin—testicular cancer	0.00324	0.00447	CbGbCtD
Dexamethasone—CYP3A4—Vinblastine—testicular cancer	0.00315	0.00435	CbGbCtD
Dexamethasone—ABCB1—Methotrexate—testicular cancer	0.00313	0.00433	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—testicular cancer	0.00305	0.00421	CbGbCtD
Dexamethasone—CYP3A4—Etoposide—testicular cancer	0.00284	0.00392	CbGbCtD
Dexamethasone—CYP19A1—Ovarian Infertility Genes—DAZL—testicular cancer	0.00224	0.109	CbGpPWpGaD
Dexamethasone—CYP3A4—Doxorubicin—testicular cancer	0.00194	0.00268	CbGbCtD
Dexamethasone—NR0B1—gonad—testicular cancer	0.00181	0.0157	CbGeAlD
Dexamethasone—CYP3A43—testis—testicular cancer	0.00157	0.0137	CbGeAlD
Dexamethasone—NR0B1—female gonad—testicular cancer	0.00147	0.0128	CbGeAlD
Dexamethasone—ANXA1—embryo—testicular cancer	0.00145	0.0126	CbGeAlD
Dexamethasone—NR3C2—Preimplantation Embryo—DNMT3L—testicular cancer	0.00139	0.0674	CbGpPWpGaD
Dexamethasone—ANXA1—seminal vesicle—testicular cancer	0.00136	0.0118	CbGeAlD
Dexamethasone—NR0B1—testis—testicular cancer	0.0013	0.0113	CbGeAlD
Dexamethasone—PLA2G1B—female gonad—testicular cancer	0.00105	0.00909	CbGeAlD
Dexamethasone—ANXA1—gonad—testicular cancer	0.000986	0.00856	CbGeAlD
Dexamethasone—CYP2A6—seminal vesicle—testicular cancer	0.000943	0.00818	CbGeAlD
Dexamethasone—PLA2G1B—testis—testicular cancer	0.000929	0.00806	CbGeAlD
Dexamethasone—CYP17A1—gonad—testicular cancer	0.000884	0.00767	CbGeAlD
Dexamethasone—NR3C2—seminal vesicle—testicular cancer	0.000884	0.00767	CbGeAlD
Dexamethasone—CYP11A1—gonad—testicular cancer	0.000822	0.00713	CbGeAlD
Dexamethasone—ANXA1—female gonad—testicular cancer	0.000801	0.00695	CbGeAlD
Dexamethasone—ABCB11—testis—testicular cancer	0.000723	0.00627	CbGeAlD
Dexamethasone—CYP17A1—female gonad—testicular cancer	0.000718	0.00623	CbGeAlD
Dexamethasone—ANXA1—testis—testicular cancer	0.000711	0.00617	CbGeAlD
Dexamethasone—NR3C1—Endoderm Differentiation—PRDM14—testicular cancer	0.000695	0.0338	CbGpPWpGaD
Dexamethasone—CYP11A1—female gonad—testicular cancer	0.000668	0.0058	CbGeAlD
Dexamethasone—ANXA1—Peptide ligand-binding receptors—INSL3—testicular cancer	0.000653	0.0318	CbGpPWpGaD
Dexamethasone—CYP17A1—testis—testicular cancer	0.000637	0.00553	CbGeAlD
Dexamethasone—CYP11A1—testis—testicular cancer	0.000593	0.00514	CbGeAlD
Dexamethasone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.000552	0.0269	CbGpPWpGaD
Dexamethasone—CYP19A1—gonad—testicular cancer	0.000534	0.00463	CbGeAlD
Dexamethasone—CYP4A11—NRF2 pathway—SLC2A6—testicular cancer	0.000521	0.0254	CbGpPWpGaD
Dexamethasone—NR3C2—female gonad—testicular cancer	0.000519	0.0045	CbGeAlD
Dexamethasone—ANXA1—lymph node—testicular cancer	0.000515	0.00447	CbGeAlD
Dexamethasone—ABCG2—seminal vesicle—testicular cancer	0.000515	0.00446	CbGeAlD
Dexamethasone—NR3C1—embryo—testicular cancer	0.000505	0.00438	CbGeAlD
Dexamethasone—CYP1B1—gonad—testicular cancer	0.000499	0.00433	CbGeAlD
Dexamethasone—PGR—female gonad—testicular cancer	0.000482	0.00418	CbGeAlD
Dexamethasone—NR3C1—seminal vesicle—testicular cancer	0.000474	0.00411	CbGeAlD
Dexamethasone—CYP17A1—lymph node—testicular cancer	0.000462	0.00401	CbGeAlD
Dexamethasone—NR3C2—testis—testicular cancer	0.00046	0.00399	CbGeAlD
Dexamethasone—CYP4A11—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000446	0.0217	CbGpPWpGaD
Dexamethasone—CYP2E1—seminal vesicle—testicular cancer	0.000445	0.00387	CbGeAlD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000438	0.0213	CbGpPWpGaD
Dexamethasone—PTGS2—embryo—testicular cancer	0.000437	0.00379	CbGeAlD
Dexamethasone—CYP19A1—female gonad—testicular cancer	0.000434	0.00377	CbGeAlD
Dexamethasone—CYP11A1—lymph node—testicular cancer	0.00043	0.00373	CbGeAlD
Dexamethasone—PGR—testis—testicular cancer	0.000428	0.00371	CbGeAlD
Dexamethasone—PTGS2—seminal vesicle—testicular cancer	0.00041	0.00356	CbGeAlD
Dexamethasone—CYP1B1—female gonad—testicular cancer	0.000406	0.00352	CbGeAlD
Dexamethasone—SLCO1A2—testis—testicular cancer	0.000394	0.00342	CbGeAlD
Dexamethasone—CYP19A1—testis—testicular cancer	0.000385	0.00334	CbGeAlD
Dexamethasone—ABCC2—testis—testicular cancer	0.000367	0.00319	CbGeAlD
Dexamethasone—CYP1B1—testis—testicular cancer	0.00036	0.00312	CbGeAlD
Dexamethasone—ABCC2—NRF2 pathway—SLC2A6—testicular cancer	0.000351	0.0171	CbGpPWpGaD
Dexamethasone—CYP2B6—gonad—testicular cancer	0.000343	0.00298	CbGeAlD
Dexamethasone—NR3C1—gonad—testicular cancer	0.000342	0.00297	CbGeAlD
Dexamethasone—NR3C2—lymph node—testicular cancer	0.000334	0.00289	CbGeAlD
Dexamethasone—ANXA1—GPCR ligand binding—INSL3—testicular cancer	0.000334	0.0162	CbGpPWpGaD
Dexamethasone—PGR—lymph node—testicular cancer	0.00031	0.00269	CbGeAlD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000307	0.0149	CbGpPWpGaD
Dexamethasone—ABCG2—female gonad—testicular cancer	0.000302	0.00262	CbGeAlD
Dexamethasone—CYP1B1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000287	0.014	CbGpPWpGaD
Dexamethasone—CYP1A1—female gonad—testicular cancer	0.000287	0.00249	CbGeAlD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000285	0.0139	CbGpPWpGaD
Dexamethasone—CYP3A5—female gonad—testicular cancer	0.00028	0.00243	CbGeAlD
Dexamethasone—CYP19A1—lymph node—testicular cancer	0.000279	0.00242	CbGeAlD
Dexamethasone—NR3C1—female gonad—testicular cancer	0.000278	0.00241	CbGeAlD
Dexamethasone—CYP2A6—NRF2 pathway—SLC2A6—testicular cancer	0.000278	0.0135	CbGpPWpGaD
Dexamethasone—CYP2C8—testis—testicular cancer	0.000276	0.00239	CbGeAlD
Dexamethasone—ABCB1—embryo—testicular cancer	0.00027	0.00234	CbGeAlD
Dexamethasone—ABCG2—testis—testicular cancer	0.000268	0.00233	CbGeAlD
Dexamethasone—ABCC2—lymph node—testicular cancer	0.000266	0.00231	CbGeAlD
Dexamethasone—CYP1B1—lymph node—testicular cancer	0.000261	0.00226	CbGeAlD
Dexamethasone—ABCB1—seminal vesicle—testicular cancer	0.000254	0.0022	CbGeAlD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—STK11—testicular cancer	0.00025	0.0122	CbGpPWpGaD
Dexamethasone—CYP2B6—testis—testicular cancer	0.000247	0.00215	CbGeAlD
Dexamethasone—NR3C1—testis—testicular cancer	0.000247	0.00214	CbGeAlD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000243	0.0118	CbGpPWpGaD
Dexamethasone—PTGS2—female gonad—testicular cancer	0.000241	0.00209	CbGeAlD
Dexamethasone—CYP3A43—Biological oxidations—HPGDS—testicular cancer	0.000239	0.0116	CbGpPWpGaD
Dexamethasone—CYP2E1—testis—testicular cancer	0.000232	0.00201	CbGeAlD
Dexamethasone—NOS2—ATF-2 transcription factor network—MMP2—testicular cancer	0.000224	0.0109	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000213	0.0104	CbGpPWpGaD
Dexamethasone—CYP2D6—female gonad—testicular cancer	0.000207	0.0018	CbGeAlD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000207	0.0101	CbGpPWpGaD
Dexamethasone—NOS2—AGE/RAGE pathway—MMP2—testicular cancer	0.000204	0.00994	CbGpPWpGaD
Dexamethasone—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000199	0.0097	CbGpPWpGaD
Dexamethasone—ABCG2—lymph node—testicular cancer	0.000194	0.00169	CbGeAlD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000189	0.0092	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—INSL3—testicular cancer	0.000188	0.00917	CbGpPWpGaD
Dexamethasone—CYP1A1—lymph node—testicular cancer	0.000184	0.0016	CbGeAlD
Dexamethasone—CYP2D6—testis—testicular cancer	0.000184	0.00159	CbGeAlD
Dexamethasone—ABCB1—gonad—testicular cancer	0.000183	0.00159	CbGeAlD
Dexamethasone—CYP17A1—Biological oxidations—HPGDS—testicular cancer	0.000183	0.00892	CbGpPWpGaD
Dexamethasone—NR3C1—lymph node—testicular cancer	0.000179	0.00155	CbGeAlD
Dexamethasone—CYP1A1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000177	0.00861	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—INSL3—testicular cancer	0.000171	0.00833	CbGpPWpGaD
Dexamethasone—CYP11A1—Biological oxidations—HPGDS—testicular cancer	0.000168	0.00816	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—DNMT3L—testicular cancer	0.000167	0.00814	CbGpPWpGaD
Dexamethasone—CYP4A11—Biological oxidations—HPGDS—testicular cancer	0.000166	0.00807	CbGpPWpGaD
Dexamethasone—CYP2C8—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000162	0.00789	CbGpPWpGaD
Dexamethasone—PTGS2—lymph node—testicular cancer	0.000155	0.00134	CbGeAlD
Dexamethasone—ABCB1—female gonad—testicular cancer	0.000149	0.00129	CbGeAlD
Dexamethasone—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000145	0.00705	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000138	0.00671	CbGpPWpGaD
Dexamethasone—Fatigue—Ifosfamide—testicular cancer	0.000136	0.000973	CcSEcCtD
Dexamethasone—Anaphylactic shock—Cisplatin—testicular cancer	0.000136	0.000973	CcSEcCtD
Dexamethasone—Oedema—Cisplatin—testicular cancer	0.000136	0.000973	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000136	0.000972	CcSEcCtD
Dexamethasone—Cardiac arrest—Epirubicin—testicular cancer	0.000135	0.000967	CcSEcCtD
Dexamethasone—Infection—Cisplatin—testicular cancer	0.000135	0.000967	CcSEcCtD
Dexamethasone—Pain—Ifosfamide—testicular cancer	0.000135	0.000965	CcSEcCtD
Dexamethasone—Cardiac failure—Doxorubicin—testicular cancer	0.000135	0.000964	CcSEcCtD
Dexamethasone—Mood swings—Epirubicin—testicular cancer	0.000135	0.000963	CcSEcCtD
Dexamethasone—Loss of consciousness—Etoposide—testicular cancer	0.000134	0.00096	CcSEcCtD
Dexamethasone—Lethargy—Doxorubicin—testicular cancer	0.000134	0.00096	CcSEcCtD
Dexamethasone—Nervous system disorder—Cisplatin—testicular cancer	0.000133	0.000954	CcSEcCtD
Dexamethasone—Thrombocytopenia—Cisplatin—testicular cancer	0.000133	0.000953	CcSEcCtD
Dexamethasone—Tachycardia—Cisplatin—testicular cancer	0.000133	0.00095	CcSEcCtD
Dexamethasone—Asthenia—Bleomycin—testicular cancer	0.000132	0.000948	CcSEcCtD
Dexamethasone—Convulsion—Etoposide—testicular cancer	0.000132	0.000947	CcSEcCtD
Dexamethasone—ABCB1—testis—testicular cancer	0.000132	0.00115	CbGeAlD
Dexamethasone—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000132	0.00642	CbGpPWpGaD
Dexamethasone—Hypertension—Etoposide—testicular cancer	0.000132	0.000943	CcSEcCtD
Dexamethasone—Osteoarthritis—Doxorubicin—testicular cancer	0.000131	0.000941	CcSEcCtD
Dexamethasone—Hyperhidrosis—Cisplatin—testicular cancer	0.000131	0.000941	CcSEcCtD
Dexamethasone—Pruritus—Bleomycin—testicular cancer	0.000131	0.000935	CcSEcCtD
Dexamethasone—Dry skin—Epirubicin—testicular cancer	0.00013	0.000932	CcSEcCtD
Dexamethasone—Feeling abnormal—Ifosfamide—testicular cancer	0.00013	0.00093	CcSEcCtD
Dexamethasone—Nausea—Vinblastine—testicular cancer	0.00013	0.000929	CcSEcCtD
Dexamethasone—Anorexia—Cisplatin—testicular cancer	0.00013	0.000928	CcSEcCtD
Dexamethasone—Affect lability—Doxorubicin—testicular cancer	0.000129	0.000926	CcSEcCtD
Dexamethasone—Migraine—Doxorubicin—testicular cancer	0.000129	0.000926	CcSEcCtD
Dexamethasone—Hypokalaemia—Epirubicin—testicular cancer	0.000129	0.000925	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000129	0.000923	CcSEcCtD
Dexamethasone—Discomfort—Etoposide—testicular cancer	0.000128	0.000919	CcSEcCtD
Dexamethasone—NR3C2—Gene Expression—DNMT3L—testicular cancer	0.000128	0.00621	CbGpPWpGaD
Dexamethasone—Hypotension—Cisplatin—testicular cancer	0.000127	0.000909	CcSEcCtD
Dexamethasone—PGR—Signaling by ERBB4—KITLG—testicular cancer	0.000126	0.00612	CbGpPWpGaD
Dexamethasone—Muscular weakness—Epirubicin—testicular cancer	0.000125	0.000897	CcSEcCtD
Dexamethasone—Urticaria—Ifosfamide—testicular cancer	0.000125	0.000897	CcSEcCtD
Dexamethasone—Cardiac arrest—Doxorubicin—testicular cancer	0.000125	0.000895	CcSEcCtD
Dexamethasone—Body temperature increased—Ifosfamide—testicular cancer	0.000125	0.000892	CcSEcCtD
Dexamethasone—Abdominal pain—Ifosfamide—testicular cancer	0.000125	0.000892	CcSEcCtD
Dexamethasone—Anaphylactic shock—Etoposide—testicular cancer	0.000125	0.000892	CcSEcCtD
Dexamethasone—Mood swings—Doxorubicin—testicular cancer	0.000124	0.000891	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000124	0.000887	CcSEcCtD
Dexamethasone—Infection—Etoposide—testicular cancer	0.000124	0.000886	CcSEcCtD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000124	0.00601	CbGpPWpGaD
Dexamethasone—Asthenia—Dactinomycin—testicular cancer	0.000123	0.000884	CcSEcCtD
Dexamethasone—Paraesthesia—Cisplatin—testicular cancer	0.000122	0.000874	CcSEcCtD
Dexamethasone—Thrombocytopenia—Etoposide—testicular cancer	0.000122	0.000873	CcSEcCtD
Dexamethasone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	0.000122	0.00593	CbGpPWpGaD
Dexamethasone—Tachycardia—Etoposide—testicular cancer	0.000122	0.00087	CcSEcCtD
Dexamethasone—Dry skin—Doxorubicin—testicular cancer	0.00012	0.000862	CcSEcCtD
Dexamethasone—Hyperhidrosis—Etoposide—testicular cancer	0.00012	0.000862	CcSEcCtD
Dexamethasone—Hypokalaemia—Doxorubicin—testicular cancer	0.00012	0.000856	CcSEcCtD
Dexamethasone—Anorexia—Etoposide—testicular cancer	0.000119	0.00085	CcSEcCtD
Dexamethasone—Decreased appetite—Cisplatin—testicular cancer	0.000118	0.000846	CcSEcCtD
Dexamethasone—Diarrhoea—Dactinomycin—testicular cancer	0.000118	0.000843	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000117	0.00084	CcSEcCtD
Dexamethasone—Vomiting—Bleomycin—testicular cancer	0.000117	0.00084	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000117	0.00568	CbGpPWpGaD
Dexamethasone—Hypotension—Etoposide—testicular cancer	0.000116	0.000833	CcSEcCtD
Dexamethasone—Rash—Bleomycin—testicular cancer	0.000116	0.000833	CcSEcCtD
Dexamethasone—Pain—Cisplatin—testicular cancer	0.000116	0.000832	CcSEcCtD
Dexamethasone—Dermatitis—Bleomycin—testicular cancer	0.000116	0.000832	CcSEcCtD
Dexamethasone—Muscular weakness—Doxorubicin—testicular cancer	0.000116	0.00083	CcSEcCtD
Dexamethasone—Conjunctivitis—Methotrexate—testicular cancer	0.000114	0.000814	CcSEcCtD
Dexamethasone—Asthenia—Ifosfamide—testicular cancer	0.000113	0.00081	CcSEcCtD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000113	0.00548	CbGpPWpGaD
Dexamethasone—Feeling abnormal—Cisplatin—testicular cancer	0.000112	0.000802	CcSEcCtD
Dexamethasone—Paraesthesia—Etoposide—testicular cancer	0.000112	0.000801	CcSEcCtD
Dexamethasone—Weight increased—Epirubicin—testicular cancer	0.000112	0.0008	CcSEcCtD
Dexamethasone—Pruritus—Ifosfamide—testicular cancer	0.000112	0.000799	CcSEcCtD
Dexamethasone—Weight decreased—Epirubicin—testicular cancer	0.000111	0.000795	CcSEcCtD
Dexamethasone—CYP19A1—Biological oxidations—HPGDS—testicular cancer	0.000111	0.0054	CbGpPWpGaD
Dexamethasone—Hyperglycaemia—Epirubicin—testicular cancer	0.000111	0.000793	CcSEcCtD
Dexamethasone—Nausea—Bleomycin—testicular cancer	0.00011	0.000785	CcSEcCtD
Dexamethasone—Vomiting—Dactinomycin—testicular cancer	0.000109	0.000783	CcSEcCtD
Dexamethasone—Rash—Dactinomycin—testicular cancer	0.000108	0.000777	CcSEcCtD
Dexamethasone—Decreased appetite—Etoposide—testicular cancer	0.000108	0.000775	CcSEcCtD
Dexamethasone—Diarrhoea—Ifosfamide—testicular cancer	0.000108	0.000772	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Etoposide—testicular cancer	0.000108	0.00077	CcSEcCtD
Dexamethasone—Body temperature increased—Cisplatin—testicular cancer	0.000107	0.000769	CcSEcCtD
Dexamethasone—Fatigue—Etoposide—testicular cancer	0.000107	0.000769	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Epirubicin—testicular cancer	0.000107	0.000768	CcSEcCtD
Dexamethasone—CYP1B1—Biological oxidations—HPGDS—testicular cancer	0.000107	0.0052	CbGpPWpGaD
Dexamethasone—Pain—Etoposide—testicular cancer	0.000106	0.000762	CcSEcCtD
Dexamethasone—Conjunctivitis—Epirubicin—testicular cancer	0.000106	0.000762	CcSEcCtD
Dexamethasone—Haemoglobin—Methotrexate—testicular cancer	0.000106	0.000756	CcSEcCtD
Dexamethasone—Haemorrhage—Methotrexate—testicular cancer	0.000105	0.000752	CcSEcCtD
Dexamethasone—Dizziness—Ifosfamide—testicular cancer	0.000104	0.000747	CcSEcCtD
Dexamethasone—Weight increased—Doxorubicin—testicular cancer	0.000103	0.00074	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—testicular cancer	0.000103	0.000736	CcSEcCtD
Dexamethasone—Feeling abnormal—Etoposide—testicular cancer	0.000103	0.000735	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—testicular cancer	0.000102	0.000734	CcSEcCtD
Dexamethasone—Nausea—Dactinomycin—testicular cancer	0.000102	0.000732	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Etoposide—testicular cancer	0.000102	0.000729	CcSEcCtD
Dexamethasone—Visual impairment—Methotrexate—testicular cancer	0.000101	0.000724	CcSEcCtD
Dexamethasone—ANXA1—Signaling Pathways—INSL3—testicular cancer	0.000101	0.00492	CbGpPWpGaD
Dexamethasone—Vomiting—Ifosfamide—testicular cancer	0.0001	0.000718	CcSEcCtD
Dexamethasone—Bradycardia—Epirubicin—testicular cancer	0.0001	0.000716	CcSEcCtD
Dexamethasone—Rash—Ifosfamide—testicular cancer	9.94e-05	0.000712	CcSEcCtD
Dexamethasone—Dermatitis—Ifosfamide—testicular cancer	9.93e-05	0.000711	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—testicular cancer	9.93e-05	0.000711	CcSEcCtD
Dexamethasone—Urticaria—Etoposide—testicular cancer	9.89e-05	0.000708	CcSEcCtD
Dexamethasone—Haemoglobin—Epirubicin—testicular cancer	9.88e-05	0.000707	CcSEcCtD
Dexamethasone—Abdominal pain—Etoposide—testicular cancer	9.84e-05	0.000705	CcSEcCtD
Dexamethasone—Body temperature increased—Etoposide—testicular cancer	9.84e-05	0.000705	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—testicular cancer	9.84e-05	0.000705	CcSEcCtD
Dexamethasone—Haemorrhage—Epirubicin—testicular cancer	9.83e-05	0.000704	CcSEcCtD
Dexamethasone—Eye disorder—Methotrexate—testicular cancer	9.81e-05	0.000703	CcSEcCtD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	9.79e-05	0.00476	CbGpPWpGaD
Dexamethasone—Asthenia—Cisplatin—testicular cancer	9.75e-05	0.000698	CcSEcCtD
Dexamethasone—CYP3A7—Biological oxidations—HPGDS—testicular cancer	9.64e-05	0.00469	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	9.62e-05	0.00468	CbGpPWpGaD
Dexamethasone—ABCB1—lymph node—testicular cancer	9.58e-05	0.000831	CbGeAlD
Dexamethasone—Angiopathy—Methotrexate—testicular cancer	9.53e-05	0.000682	CcSEcCtD
Dexamethasone—Visual impairment—Epirubicin—testicular cancer	9.47e-05	0.000678	CcSEcCtD
Dexamethasone—Nausea—Ifosfamide—testicular cancer	9.37e-05	0.000671	CcSEcCtD
Dexamethasone—PGR—Signaling by ERBB4—FGFR3—testicular cancer	9.34e-05	0.00455	CbGpPWpGaD
Dexamethasone—Diarrhoea—Cisplatin—testicular cancer	9.3e-05	0.000666	CcSEcCtD
Dexamethasone—Alopecia—Methotrexate—testicular cancer	9.28e-05	0.000664	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—testicular cancer	9.25e-05	0.000663	CcSEcCtD
Dexamethasone—Eye disorder—Epirubicin—testicular cancer	9.18e-05	0.000657	CcSEcCtD
Dexamethasone—Erythema—Methotrexate—testicular cancer	9.14e-05	0.000654	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—testicular cancer	9.14e-05	0.000654	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—testicular cancer	9.09e-05	0.000651	CcSEcCtD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—STK11—testicular cancer	8.95e-05	0.00436	CbGpPWpGaD
Dexamethasone—Asthenia—Etoposide—testicular cancer	8.93e-05	0.00064	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—testicular cancer	8.91e-05	0.000638	CcSEcCtD
Dexamethasone—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	8.85e-05	0.00431	CbGpPWpGaD
Dexamethasone—CYP2A6—Biological oxidations—HPGDS—testicular cancer	8.84e-05	0.0043	CbGpPWpGaD
Dexamethasone—Pruritus—Etoposide—testicular cancer	8.81e-05	0.000631	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—testicular cancer	8.78e-05	0.000628	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—testicular cancer	8.76e-05	0.000627	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—testicular cancer	8.68e-05	0.000622	CcSEcCtD
Dexamethasone—Vomiting—Cisplatin—testicular cancer	8.64e-05	0.000619	CcSEcCtD
Dexamethasone—PGR—Signaling by ERBB4—KIT—testicular cancer	8.58e-05	0.00417	CbGpPWpGaD
Dexamethasone—Rash—Cisplatin—testicular cancer	8.57e-05	0.000614	CcSEcCtD
Dexamethasone—Dermatitis—Cisplatin—testicular cancer	8.56e-05	0.000613	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—testicular cancer	8.55e-05	0.000612	CcSEcCtD
Dexamethasone—Diarrhoea—Etoposide—testicular cancer	8.52e-05	0.00061	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—testicular cancer	8.5e-05	0.000608	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—testicular cancer	8.48e-05	0.000607	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—testicular cancer	8.25e-05	0.000591	CcSEcCtD
Dexamethasone—Malaise—Methotrexate—testicular cancer	8.24e-05	0.00059	CcSEcCtD
Dexamethasone—Dizziness—Etoposide—testicular cancer	8.23e-05	0.00059	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—testicular cancer	8.21e-05	0.000588	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—testicular cancer	8.12e-05	0.000582	CcSEcCtD
Dexamethasone—Nausea—Cisplatin—testicular cancer	8.07e-05	0.000578	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—testicular cancer	8.03e-05	0.000575	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—testicular cancer	7.94e-05	0.000568	CcSEcCtD
Dexamethasone—Convulsion—Methotrexate—testicular cancer	7.92e-05	0.000567	CcSEcCtD
Dexamethasone—Vomiting—Etoposide—testicular cancer	7.92e-05	0.000567	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—testicular cancer	7.91e-05	0.000567	CcSEcCtD
Dexamethasone—Rash—Etoposide—testicular cancer	7.85e-05	0.000562	CcSEcCtD
Dexamethasone—Dermatitis—Etoposide—testicular cancer	7.84e-05	0.000562	CcSEcCtD
Dexamethasone—Headache—Etoposide—testicular cancer	7.8e-05	0.000559	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—testicular cancer	7.78e-05	0.000557	CcSEcCtD
Dexamethasone—PGR—Gene Expression—DNMT3L—testicular cancer	7.78e-05	0.00378	CbGpPWpGaD
Dexamethasone—Malaise—Epirubicin—testicular cancer	7.71e-05	0.000552	CcSEcCtD
Dexamethasone—Discomfort—Methotrexate—testicular cancer	7.69e-05	0.00055	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—testicular cancer	7.68e-05	0.00055	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—testicular cancer	7.67e-05	0.000549	CcSEcCtD
Dexamethasone—Loss of consciousness—Epirubicin—testicular cancer	7.52e-05	0.000538	CcSEcCtD
Dexamethasone—Anaphylactic shock—Methotrexate—testicular cancer	7.46e-05	0.000534	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—testicular cancer	7.41e-05	0.000531	CcSEcCtD
Dexamethasone—Infection—Methotrexate—testicular cancer	7.41e-05	0.000531	CcSEcCtD
Dexamethasone—Nausea—Etoposide—testicular cancer	7.4e-05	0.00053	CcSEcCtD
Dexamethasone—Hypertension—Epirubicin—testicular cancer	7.38e-05	0.000529	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—testicular cancer	7.34e-05	0.000526	CcSEcCtD
Dexamethasone—Nervous system disorder—Methotrexate—testicular cancer	7.31e-05	0.000524	CcSEcCtD
Dexamethasone—Thrombocytopenia—Methotrexate—testicular cancer	7.3e-05	0.000523	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—testicular cancer	7.28e-05	0.000521	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—testicular cancer	7.26e-05	0.00052	CcSEcCtD
Dexamethasone—Hyperhidrosis—Methotrexate—testicular cancer	7.21e-05	0.000516	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—testicular cancer	7.19e-05	0.000515	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—testicular cancer	7.14e-05	0.000511	CcSEcCtD
Dexamethasone—CYP2B6—Biological oxidations—HPGDS—testicular cancer	7.13e-05	0.00347	CbGpPWpGaD
Dexamethasone—Vertigo—Doxorubicin—testicular cancer	7.11e-05	0.000509	CcSEcCtD
Dexamethasone—Anorexia—Methotrexate—testicular cancer	7.11e-05	0.000509	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—testicular cancer	7.1e-05	0.000508	CcSEcCtD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.04e-05	0.00342	CbGpPWpGaD
Dexamethasone—CYP2E1—Biological oxidations—HPGDS—testicular cancer	6.98e-05	0.0034	CbGpPWpGaD
Dexamethasone—Oedema—Epirubicin—testicular cancer	6.98e-05	0.0005	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—testicular cancer	6.98e-05	0.0005	CcSEcCtD
Dexamethasone—Hypotension—Methotrexate—testicular cancer	6.97e-05	0.000499	CcSEcCtD
Dexamethasone—CYP3A5—Biological oxidations—HPGDS—testicular cancer	6.97e-05	0.00339	CbGpPWpGaD
Dexamethasone—Loss of consciousness—Doxorubicin—testicular cancer	6.96e-05	0.000498	CcSEcCtD
Dexamethasone—Infection—Epirubicin—testicular cancer	6.93e-05	0.000497	CcSEcCtD
Dexamethasone—Shock—Epirubicin—testicular cancer	6.87e-05	0.000492	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—testicular cancer	6.86e-05	0.000491	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—testicular cancer	6.85e-05	0.00049	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—testicular cancer	6.83e-05	0.000489	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—testicular cancer	6.83e-05	0.000489	CcSEcCtD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	6.82e-05	0.00332	CbGpPWpGaD
Dexamethasone—Tachycardia—Epirubicin—testicular cancer	6.81e-05	0.000488	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—testicular cancer	6.8e-05	0.000487	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—testicular cancer	6.75e-05	0.000483	CcSEcCtD
Dexamethasone—Insomnia—Methotrexate—testicular cancer	6.75e-05	0.000483	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—testicular cancer	6.74e-05	0.000482	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—testicular cancer	6.71e-05	0.000481	CcSEcCtD
Dexamethasone—Paraesthesia—Methotrexate—testicular cancer	6.7e-05	0.00048	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—testicular cancer	6.66e-05	0.000477	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—testicular cancer	6.65e-05	0.000476	CcSEcCtD
Dexamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	6.59e-05	0.00321	CbGpPWpGaD
Dexamethasone—CYP1A1—Biological oxidations—HPGDS—testicular cancer	6.58e-05	0.0032	CbGpPWpGaD
Dexamethasone—Dyspepsia—Methotrexate—testicular cancer	6.57e-05	0.00047	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—testicular cancer	6.52e-05	0.000467	CcSEcCtD
Dexamethasone—Decreased appetite—Methotrexate—testicular cancer	6.48e-05	0.000464	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—testicular cancer	6.46e-05	0.000462	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—testicular cancer	6.46e-05	0.000462	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Methotrexate—testicular cancer	6.44e-05	0.000461	CcSEcCtD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.44e-05	0.00313	CbGpPWpGaD
Dexamethasone—Fatigue—Methotrexate—testicular cancer	6.43e-05	0.00046	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—testicular cancer	6.42e-05	0.000459	CcSEcCtD
Dexamethasone—Pain—Methotrexate—testicular cancer	6.38e-05	0.000457	CcSEcCtD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.37e-05	0.0031	CbGpPWpGaD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—testicular cancer	6.36e-05	0.000455	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—testicular cancer	6.35e-05	0.000455	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—testicular cancer	6.33e-05	0.000454	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—testicular cancer	6.32e-05	0.000453	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—testicular cancer	6.31e-05	0.000452	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—testicular cancer	6.3e-05	0.000451	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—testicular cancer	6.27e-05	0.000449	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—testicular cancer	6.24e-05	0.000447	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—testicular cancer	6.16e-05	0.000441	CcSEcCtD
Dexamethasone—Feeling abnormal—Methotrexate—testicular cancer	6.15e-05	0.00044	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—testicular cancer	6.14e-05	0.00044	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Methotrexate—testicular cancer	6.1e-05	0.000437	CcSEcCtD
Dexamethasone—Decreased appetite—Epirubicin—testicular cancer	6.07e-05	0.000434	CcSEcCtD
Dexamethasone—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	6.04e-05	0.00294	CbGpPWpGaD
Dexamethasone—CYP2C8—Biological oxidations—HPGDS—testicular cancer	6.04e-05	0.00294	CbGpPWpGaD
Dexamethasone—Hypotension—Doxorubicin—testicular cancer	6.04e-05	0.000432	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—testicular cancer	6.03e-05	0.000432	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—testicular cancer	6.02e-05	0.000431	CcSEcCtD
Dexamethasone—Pain—Epirubicin—testicular cancer	5.97e-05	0.000427	CcSEcCtD
Dexamethasone—Urticaria—Methotrexate—testicular cancer	5.93e-05	0.000424	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—testicular cancer	5.9e-05	0.000422	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—testicular cancer	5.9e-05	0.000422	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	5.88e-05	0.000421	CcSEcCtD
Dexamethasone—NR0B1—Gene Expression—H2AFZ—testicular cancer	5.85e-05	0.00285	CbGpPWpGaD
Dexamethasone—Insomnia—Doxorubicin—testicular cancer	5.84e-05	0.000418	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—testicular cancer	5.8e-05	0.000415	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—testicular cancer	5.75e-05	0.000412	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—testicular cancer	5.71e-05	0.000409	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—testicular cancer	5.69e-05	0.000407	CcSEcCtD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.65e-05	0.00275	CbGpPWpGaD
Dexamethasone—Decreased appetite—Doxorubicin—testicular cancer	5.61e-05	0.000402	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—testicular cancer	5.58e-05	0.000399	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—testicular cancer	5.57e-05	0.000399	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—testicular cancer	5.55e-05	0.000397	CcSEcCtD
Dexamethasone—PGR—Signaling Pathways—INSL3—testicular cancer	5.53e-05	0.00269	CbGpPWpGaD
Dexamethasone—Pain—Doxorubicin—testicular cancer	5.52e-05	0.000395	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—testicular cancer	5.52e-05	0.000395	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—testicular cancer	5.52e-05	0.000395	CcSEcCtD
Dexamethasone—CYP2C19—Biological oxidations—HPGDS—testicular cancer	5.39e-05	0.00262	CbGpPWpGaD
Dexamethasone—Asthenia—Methotrexate—testicular cancer	5.35e-05	0.000383	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—testicular cancer	5.32e-05	0.000381	CcSEcCtD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.29e-05	0.00257	CbGpPWpGaD
Dexamethasone—Gastrointestinal pain—Doxorubicin—testicular cancer	5.28e-05	0.000378	CcSEcCtD
Dexamethasone—Pruritus—Methotrexate—testicular cancer	5.28e-05	0.000378	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism—HPGDS—testicular cancer	5.2e-05	0.00253	CbGpPWpGaD
Dexamethasone—Urticaria—Doxorubicin—testicular cancer	5.13e-05	0.000367	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—testicular cancer	5.11e-05	0.000366	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—testicular cancer	5.11e-05	0.000366	CcSEcCtD
Dexamethasone—Diarrhoea—Methotrexate—testicular cancer	5.1e-05	0.000365	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—testicular cancer	5.01e-05	0.000359	CcSEcCtD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	4.96e-05	0.00241	CbGpPWpGaD
Dexamethasone—CYP2D6—Biological oxidations—HPGDS—testicular cancer	4.96e-05	0.00241	CbGpPWpGaD
Dexamethasone—Pruritus—Epirubicin—testicular cancer	4.94e-05	0.000354	CcSEcCtD
Dexamethasone—Dizziness—Methotrexate—testicular cancer	4.93e-05	0.000353	CcSEcCtD
Dexamethasone—CYP2C9—Biological oxidations—HPGDS—testicular cancer	4.91e-05	0.00239	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	4.84e-05	0.00235	CbGpPWpGaD
Dexamethasone—Diarrhoea—Epirubicin—testicular cancer	4.78e-05	0.000342	CcSEcCtD
Dexamethasone—Vomiting—Methotrexate—testicular cancer	4.74e-05	0.00034	CcSEcCtD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.72e-05	0.0023	CbGpPWpGaD
Dexamethasone—Rash—Methotrexate—testicular cancer	4.7e-05	0.000337	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—testicular cancer	4.7e-05	0.000336	CcSEcCtD
Dexamethasone—Headache—Methotrexate—testicular cancer	4.67e-05	0.000335	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—testicular cancer	4.63e-05	0.000332	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—testicular cancer	4.62e-05	0.000331	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—testicular cancer	4.57e-05	0.000327	CcSEcCtD
Dexamethasone—NR3C1—Gene Expression—DNMT3L—testicular cancer	4.5e-05	0.00219	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—H2AFZ—testicular cancer	4.47e-05	0.00217	CbGpPWpGaD
Dexamethasone—Vomiting—Epirubicin—testicular cancer	4.44e-05	0.000318	CcSEcCtD
Dexamethasone—Nausea—Methotrexate—testicular cancer	4.43e-05	0.000317	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—testicular cancer	4.42e-05	0.000316	CcSEcCtD
Dexamethasone—Rash—Epirubicin—testicular cancer	4.4e-05	0.000315	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—testicular cancer	4.4e-05	0.000315	CcSEcCtD
Dexamethasone—Headache—Epirubicin—testicular cancer	4.37e-05	0.000313	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—testicular cancer	4.27e-05	0.000306	CcSEcCtD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.26e-05	0.00207	CbGpPWpGaD
Dexamethasone—Nausea—Epirubicin—testicular cancer	4.15e-05	0.000297	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—testicular cancer	4.11e-05	0.000294	CcSEcCtD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.11e-05	0.002	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—HPGDS—testicular cancer	4.09e-05	0.00199	CbGpPWpGaD
Dexamethasone—Rash—Doxorubicin—testicular cancer	4.07e-05	0.000292	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—testicular cancer	4.07e-05	0.000291	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—testicular cancer	4.05e-05	0.00029	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—testicular cancer	3.84e-05	0.000275	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism—STK11—testicular cancer	3.78e-05	0.00184	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	3.51e-05	0.00171	CbGpPWpGaD
Dexamethasone—NOS2—Disease—H2AFZ—testicular cancer	3.49e-05	0.0017	CbGpPWpGaD
Dexamethasone—CYP3A4—Biological oxidations—HPGDS—testicular cancer	3.24e-05	0.00158	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—H2AFZ—testicular cancer	3.24e-05	0.00158	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—STK11—testicular cancer	3.22e-05	0.00157	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KITLG—testicular cancer	3.21e-05	0.00156	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—HPGDS—testicular cancer	3.13e-05	0.00153	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KITLG—testicular cancer	2.98e-05	0.00145	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—STK11—testicular cancer	2.97e-05	0.00145	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—HPGDS—testicular cancer	2.87e-05	0.00139	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.85e-05	0.00139	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—HPGDS—testicular cancer	2.84e-05	0.00138	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—H2AFZ—testicular cancer	2.72e-05	0.00132	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.53e-05	0.00123	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—HPGDS—testicular cancer	2.52e-05	0.00122	CbGpPWpGaD
Dexamethasone—NOS2—Disease—FGFR3—testicular cancer	2.38e-05	0.00116	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.32e-05	0.00113	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—STK11—testicular cancer	2.28e-05	0.00111	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—FGFR3—testicular cancer	2.21e-05	0.00108	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KIT—testicular cancer	2.19e-05	0.00107	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—HPGDS—testicular cancer	2.1e-05	0.00102	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—STK11—testicular cancer	2.08e-05	0.00101	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.07e-05	0.00101	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—STK11—testicular cancer	2.06e-05	0.001	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KIT—testicular cancer	2.03e-05	0.000989	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—HPGDS—testicular cancer	1.9e-05	0.000924	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.89e-05	0.000918	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—HPGDS—testicular cancer	1.83e-05	0.00089	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—STK11—testicular cancer	1.83e-05	0.00089	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—H2AFZ—testicular cancer	1.77e-05	0.000861	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—STK11—testicular cancer	1.76e-05	0.000856	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—HPGDS—testicular cancer	1.66e-05	0.00081	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—HPGDS—testicular cancer	1.65e-05	0.000802	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KITLG—testicular cancer	1.63e-05	0.000792	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—H2AFZ—testicular cancer	1.57e-05	0.000766	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—STK11—testicular cancer	1.53e-05	0.000743	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—HPGDS—testicular cancer	1.51e-05	0.000735	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—STK11—testicular cancer	1.38e-05	0.000671	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—STK11—testicular cancer	1.33e-05	0.000646	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—HPGDS—testicular cancer	1.27e-05	0.000617	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—HPGDS—testicular cancer	1.22e-05	0.000593	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—FGFR3—testicular cancer	1.21e-05	0.000589	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—STK11—testicular cancer	1.21e-05	0.000588	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—STK11—testicular cancer	1.2e-05	0.000583	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—HPGDS—testicular cancer	1.19e-05	0.000581	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—HPGDS—testicular cancer	1.19e-05	0.00058	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—HPGDS—testicular cancer	1.13e-05	0.000548	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KIT—testicular cancer	1.11e-05	0.000541	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—H2AFZ—testicular cancer	1.11e-05	0.000539	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—STK11—testicular cancer	1.1e-05	0.000534	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—HPGDS—testicular cancer	1.03e-05	0.000502	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KITLG—testicular cancer	1.02e-05	0.000496	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—STK11—testicular cancer	9.22e-06	0.000449	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—HPGDS—testicular cancer	9.21e-06	0.000448	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—HPGDS—testicular cancer	8.99e-06	0.000438	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—STK11—testicular cancer	8.86e-06	0.000431	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—STK11—testicular cancer	8.68e-06	0.000422	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—STK11—testicular cancer	8.66e-06	0.000421	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—HPGDS—testicular cancer	8.47e-06	0.000412	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—HPGDS—testicular cancer	8.4e-06	0.000409	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—STK11—testicular cancer	8.18e-06	0.000398	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FGFR3—testicular cancer	7.57e-06	0.000368	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—STK11—testicular cancer	7.5e-06	0.000365	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KIT—testicular cancer	6.95e-06	0.000338	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—STK11—testicular cancer	6.69e-06	0.000326	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—STK11—testicular cancer	6.53e-06	0.000318	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—STK11—testicular cancer	6.16e-06	0.0003	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—STK11—testicular cancer	6.1e-06	0.000297	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HPGDS—testicular cancer	5.54e-06	0.00027	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—STK11—testicular cancer	4.03e-06	0.000196	CbGpPWpGaD
